Delivery Order SPE2DB20D6037-SPE2DB23FD0PN
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,145.42 firm fixed-price delivery order is for the supply of 4,566,779,622 tablets of Fexofenadine HCL 180 mg, with a completion date of December 6, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order valued at $1,903.78 for the provision of Fexofenadine HCL 180 mg tablets. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999. The order, valued at $7,400.64, is for the supply of a wide range of pharmaceutical products, including both branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These products are to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 4,567,133,666 units of Fexofenadine HCL 180 mg tablets to support the medical supply needs of military healthcare facilities. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities. The contract, valued at up to $1,643.90, is a delivery order issued under the Defense Logistics Agency's (DLA) SPE2DB program, a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. This contract allows...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a $37,053.68 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB contract vehicle. The SPE2DB contract is an indefinite delivery contract (IDC) valued up to $499,999,999 that allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,436.40 contract covers the delivery of 500 tablets of fexofenadine hydrochloride 180 mg to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB23FD0PNDelivery Order
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $1,571.95 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract is for the delivery of 4,561,591,012 units of fexofenadine HCl 180 mg tablets to support the recurring pharmaceutical supply needs of military health facilities worldwide. The SPE2DB program is a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that allows the DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products. Through this contract vehicle, DMS Pharmaceutical Group provides both routine and critical medications to various Department of Defense (DoD) healthcare facilities, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain. This delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/25/23 |